The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,861,418 in first-year total cost, median $225,000.
Most frequent study sections
- Special Emphasis Panel[ZRG1 CVRS-C (10)]2
- Special Emphasis Panel[ZRG1 IMST-J (15)]2
- Special Emphasis Panel[ZRG1 DKUS-N (11)]1
Most frequent institutions
- BELL BIOSYSTEMS, INC.2
- IMANIS LIFE SCIENCES, LLC1
- PROBETEX, INC.1
- RECOMBINETICS, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Tracking cardiac engraftment and viability of MiPSC by MRI2R44EB019239-02 | BELL, CALEB B.SVENDSEN, CLIVE NIELSYANG, PHILLIP CHUNG-MING | BELL BIOSYSTEMS, INC., CA | $983,354 | ZRG1 |
| 2015 | Multiplex gene-editing to create multi-lineage ablated hosts for exogenic organ production1R43GM113525-01 | CARLSON, DANIEL FREDGARRY, DANIEL J. | RECOMBINETICS, INC., MN | $301,098 | ZRG1 |
| 2015 | Longitudinal In Vivo Imaging of NIS Expressing Stem Cells1R43GM112316-01A1 | IKEDA, YASUHIROSUKSANPAISAN, LUKKANA | IMANIS LIFE SCIENCES, LLC, MN | $202,754 | ZRG1 |
| 2014 | Tracking cardiac engraftment and viability of MiPSC by MRI1R43EB019239-01 | BAZAROV, ALEXEYBELL, CALEB B.YANG, PHILLIP CHUNG-MING | BELL BIOSYSTEMS, INC., CA | $225,000 | ZRG1 |
| 2014 | Kidney Progenitor Cells in Regenerative Medicine1R43GM110837-01 | BARNES, VERONIQUE L | PROBETEX, INC., TX | $149,212 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.